F&G Annuities & Life (FGN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $22.63, -1.65% vs the prior close of $23.01.
- Volume 35.74K shares, 1.5x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FGN dips 1.7% to $22.63. Closed at $22.63, -1.65% vs the prior close of $23.01. Day range $22.63β$23.19, opened at $23.05.
FGN daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β FGN dips 1.7% to $22.63
- Closed at $22.63, -1.65% vs the prior close of $23.01. Day range $22.63β$23.19, opened at $23.05.
- Volume was 35.74K shares, 1.5x its 50-day average of 23.27K.
- Price is -6.5% vs its 50-day average ($24.20) and -9.0% vs its 200-day average ($24.86).
- 52-week range $22.48β$26.97; today's close sits at 3% of that range, 16.1% below the 52-week high.
Oct 15, 2026 β FGN rises 1.9% to $23.01
- Closed at $23.01, +1.90% vs the prior close of $22.58. Day range $22.71β$23.27, opened at $22.71.
- Volume was 33.60K shares, 1.5x its 50-day average of 23.02K.
- Price is -5.1% vs its 50-day average ($24.23) and -7.5% vs its 200-day average ($24.88).
- 52-week range $22.48β$26.97; today's close sits at 12% of that range, 14.7% below the 52-week high.
Oct 14, 2026 β FGN dips 2.7% to $22.58, a 52-week low on 1.9x normal volume
- Closed at $22.58, -2.67% vs the prior close of $23.20. Day range $22.48β$23.17, opened at $23.15.
- Volume was 42.20K shares, 1.9x its 50-day average of 22.61K β unusually heavy trading.
- Price is -6.9% vs its 50-day average ($24.26) and -9.3% vs its 200-day average ($24.89).
- 52-week range $22.48β$26.97; today's close sits at 2% of that range, 16.3% below the 52-week high.
Oct 13, 2026 β FGN rises 0.9% to $23.20
- Closed at $23.20, +0.91% vs the prior close of $22.99. Day range $22.95β$23.40, opened at $23.14.
- Volume was 25.90K shares, 1.2x its 50-day average of 22.32K.
- Price is -4.6% vs its 50-day average ($24.31) and -6.8% vs its 200-day average ($24.90).
- 52-week range $22.95β$26.97; today's close sits at 6% of that range, 14.0% below the 52-week high.
Oct 12, 2026 β FGN dips 1.0% to $22.99, a 52-week low
- Closed at $22.99, -0.99% vs the prior close of $23.22. Day range $22.96β$23.76, opened at $23.12.
- Volume was 17.90K shares, 0.8x its 50-day average of 22.66K.
- Price is -5.5% vs its 50-day average ($24.34) and -7.7% vs its 200-day average ($24.91).
- 52-week range $22.96β$26.97; today's close sits at 1% of that range, 14.8% below the 52-week high.
Oct 9, 2026 β FGN rises 0.4% to $23.22
- Closed at $23.22, +0.43% vs the prior close of $23.12. Day range $23.10β$23.61, opened at $23.33.
- Volume was 18.40K shares, 0.8x its 50-day average of 22.61K.
- Price is -4.7% vs its 50-day average ($24.37) and -6.8% vs its 200-day average ($24.93).
- 52-week range $23.01β$26.97; today's close sits at 5% of that range, 13.9% below the 52-week high.
Oct 8, 2026 β FGN dips 0.3% to $23.12, a 52-week low, 3 down days in a row
- Closed at $23.12, -0.34% vs the prior close of $23.20. Day range $23.01β$23.61, opened at $23.25.
- Volume was 19.80K shares, 0.9x its 50-day average of 22.65K.
- Price is -5.2% vs its 50-day average ($24.40) and -7.3% vs its 200-day average ($24.94).
- 52-week range $23.01β$26.97; today's close sits at 3% of that range, 14.3% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β FGN dips 2.6% to $23.20, a 52-week low
- Closed at $23.20, -2.64% vs the prior close of $23.83. Day range $23.15β$23.79, opened at $23.68.
- Volume was 33.50K shares, 1.5x its 50-day average of 22.48K.
- Price is -5.1% vs its 50-day average ($24.43) and -7.0% vs its 200-day average ($24.95).
- 52-week range $23.10β$26.97; today's close sits at 3% of that range, 14.0% below the 52-week high.
Oct 6, 2026 β FGN ends flat (-0.0%) to $23.83
- Closed at $23.83, -0.04% vs the prior close of $23.84. Day range $23.54β$24.04, opened at $23.76.
- Volume was 25.40K shares, 1.1x its 50-day average of 22.23K.
- Price is -2.6% vs its 50-day average ($24.47) and -4.5% vs its 200-day average ($24.96).
- 52-week range $23.10β$26.97; today's close sits at 19% of that range, 11.6% below the 52-week high.
Oct 5, 2026 β FGN rises 0.4% to $23.84
- Closed at $23.84, +0.38% vs the prior close of $23.75. Day range $23.50β$23.98, opened at $23.74.
- Volume was 25.20K shares, 1.1x its 50-day average of 21.93K.
- Price is -2.6% vs its 50-day average ($24.48) and -4.5% vs its 200-day average ($24.97).
- 52-week range $23.10β$26.97; today's close sits at 19% of that range, 11.6% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 2, 2026 β FGN ends flat (-0.2%) to $23.75
- Closed at $23.75, -0.21% vs the prior close of $23.80. Day range $23.50β$24.12, opened at $23.93.
- Volume was 19.60K shares, 0.9x its 50-day average of 21.68K.
- Price is -3.1% vs its 50-day average ($24.50) and -4.9% vs its 200-day average ($24.98).
- 52-week range $23.10β$26.97; today's close sits at 17% of that range, 11.9% below the 52-week high.
FGN latest news & SEC filings
Every SEC filing by or about FGN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Quirk Raymond R received an award of 1,252 shares at $21.98 (β$27.52K) on Oct 1, 2026; now holds 15,140
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Nolan Michael Joseph received an award of 1,252 shares at $21.98 (β$27.52K) on Oct 1, 2026; now holds 82,254
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Ammerman Douglas K received an award of 1,013 shares at $21.98 (β$22.27K) on Oct 1, 2026; now holds 65,916
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 2, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Murphy Conor bought 231 shares at $21.68 (β$5.01K) on Sep 30, 2026; now holds 196,991
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 15, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 6, 2026 Β· Form 3 β New insider holdings
Initial insider ownership statement (Form 3) β a new director, officer or 10% owner disclosed their holdings
Aug 6, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.42B (prior year $1.36B) (+4.2% vs Jun 30, 2025)
- Net income: -$76.00M (prior year $40.00M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.62 (prior year $0.26) (loss widened vs Jun 30, 2025)
Aug 5, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 8, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 25, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
Things to know before you trade FGN
- Last results release: Oct 5, 2026 (8-K Item 2.02). Previous ones: Aug 5, 2026, Jul 8, 2026, May 6, 2026. Based on that rhythm, the next report is likely around Jan 4, 2027 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.85% (largest 2.7%). That is a relatively calm stock.
- Liquidity: about 25.82K shares (β$584.24K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $22.63 vs a range of $22.48β$26.97 (3% of the range).
- Dividends: last ex-dividend date Sep 1, 2026 ($0.497/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 16 open-market buys, 0 sales; latest: Christopher O Blunt bought 10,000 shares on Mar 13, 2026.
- Latest filings: 8-K Oct 5, 2026; 10-Q Aug 6, 2026; 8-K Aug 5, 2026.
- Share count: 130.94M shares outstanding (Jul 31, 2026), -2.8% vs a year earlier β the company has been reducing its share count.
- Listing: NYSE Β· industry: Life Insurance.
FGN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 23.05 | 23.19 | 22.63 | 22.63 | 35.74K |
| Oct 15, 2026 | 22.71 | 23.27 | 22.71 | 23.01 | 33.60K |
| Oct 14, 2026 | 23.15 | 23.17 | 22.48 | 22.58 | 42.20K |
| Oct 13, 2026 | 23.14 | 23.40 | 22.95 | 23.20 | 25.90K |
| Oct 12, 2026 | 23.12 | 23.76 | 22.96 | 22.99 | 17.90K |
| Oct 9, 2026 | 23.33 | 23.61 | 23.10 | 23.22 | 18.40K |
| Oct 8, 2026 | 23.25 | 23.61 | 23.01 | 23.12 | 19.80K |
| Oct 7, 2026 | 23.68 | 23.79 | 23.15 | 23.20 | 33.50K |
| Oct 6, 2026 | 23.76 | 24.04 | 23.54 | 23.83 | 25.40K |
| Oct 5, 2026 | 23.74 | 23.98 | 23.50 | 23.84 | 25.20K |
| Oct 2, 2026 | 23.93 | 24.12 | 23.50 | 23.75 | 19.60K |
| Oct 1, 2026 | 23.77 | 24.18 | 23.68 | 23.80 | 31.20K |
| Sep 30, 2026 | 23.94 | 24.18 | 23.30 | 23.68 | 89.00K |
| Sep 29, 2026 | 23.83 | 24.13 | 23.74 | 23.85 | 16.40K |
| Sep 28, 2026 | 24.28 | 24.28 | 23.67 | 23.91 | 24.00K |
| Sep 25, 2026 | 24.33 | 24.52 | 24.16 | 24.28 | 14.40K |
| Sep 24, 2026 | 24.30 | 24.37 | 24.21 | 24.33 | 8.70K |
| Sep 23, 2026 | 24.55 | 24.55 | 24.30 | 24.37 | 12.00K |
| Sep 22, 2026 | 24.69 | 24.73 | 24.58 | 24.66 | 10.50K |
| Sep 21, 2026 | 24.80 | 24.85 | 24.58 | 24.65 | 12.90K |
About F&G Annuities & Life
F&G Annuities & Life (FGN) is listed on the NYSE and classified by the SEC under βLife Insuranceβ. Its business address is in DES MOINES, IA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1934850.
FGN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Douglas K Ammerman | Director | Jul 6, 2026 |
| Christopher O Blunt | Chief Executive Officer | Mar 13, 2026 |
| Celina J. Wang Doka | Director | Mar 13, 2026 |
| William P Ii Foley | Executive Chairman | Mar 3, 2026 |
| Douglas Martinez | Director | Nov 13, 2025 |
| Michael Joseph Nolan | Director | Jul 6, 2026 |
| Raymond R Quirk | Director | Jul 6, 2026 |
| John D Rood | Director | Feb 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael H Bailey | EVP, Chief Financial Officer | Sep 15, 2026 |
| Christopher O Blunt | Chief Executive Officer | Mar 13, 2026 |
| John David Jr. Currier | EVP, Senior Advisor | Dec 3, 2025 |
| William P Ii Foley | Executive Chairman | Mar 3, 2026 |
| Michael L Gravelle | EVP, General Counsel & Corp S | Apr 3, 2026 |
| Conor Murphy | President and CFO | Apr 3, 2026 |
| Leena Punjabi | EVP, Chief Investment Officer | Dec 3, 2025 |
| Mark Wiltse | Interim CFO | Jul 6, 2026 |
| Wendy J.B. Young | EVP, CLO & Treasurer | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 13, 2026 | Christopher O Blunt | Buy | 10,000 | $20.99 |
| Mar 13, 2026 | Christopher O Blunt | Buy | 10,000 | $20.99 |
| Mar 13, 2026 | Christopher O Blunt | Buy | 10,000 | $20.99 |
| Mar 13, 2026 | Christopher O Blunt | Buy | 10,000 | $20.99 |
| Mar 13, 2026 | Celina J. Wang Doka | Buy | 4,760 | $20.98 |
| Mar 13, 2026 | Celina J. Wang Doka | Buy | 4,760 | $20.98 |
| Mar 13, 2026 | Celina J. Wang Doka | Buy | 4,760 | $20.98 |
| Mar 13, 2026 | Celina J. Wang Doka | Buy | 4,760 | $20.98 |
| Jan 2, 2026 | Christopher O Blunt | Buy | 5,000 | $29.56 |
| Jan 2, 2026 | Christopher O Blunt | Buy | 5,000 | $29.56 |
| Jan 2, 2026 | Christopher O Blunt | Buy | 5,000 | $29.56 |
| Jan 2, 2026 | Christopher O Blunt | Buy | 5,000 | $29.56 |
| Nov 19, 2025 | Christopher O Blunt | Buy | 5,000 | $29.88 |
| Nov 19, 2025 | Christopher O Blunt | Buy | 5,000 | $29.88 |
| Nov 19, 2025 | Christopher O Blunt | Buy | 5,000 | $29.88 |
FGN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $5.73B | $265.00M | 1.88 | $4.68B |
| Dec 31, 2024 | $5.74B | $639.00M | 4.88 | $6.00B |
| Dec 31, 2023 | $4.50B | $-58.00M | -0.47 | $5.83B |
| Dec 31, 2022 | $2.35B | $635.00M | 5.52 | $3.17B |
| Dec 31, 2021 | $3.97B | $1.24B | 11.81 | $1.87B |
Latest balance sheet: total assets $103.59B, total liabilities $98.90B, cash $2.10B (as of Jun 30, 2026).
FGN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 5, 2026 | 8-K Item 2.02 (results) | $23.84 |
| Aug 5, 2026 | 8-K Item 2.02 (results) | $24.49 |
| Jul 8, 2026 | 8-K Item 2.02 (results) | $24.92 |
| May 6, 2026 | 8-K Item 2.02 (results) | $25.03 |
| Feb 19, 2026 | 8-K Item 2.02 (results) | $26.27 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $26.46 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $26.84 |
| May 7, 2025 | 8-K Item 2.02 (results) | $25.90 |
| Feb 20, 2025 | 8-K Item 2.02 (results) | $26.58 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $27.10 |
| Aug 5, 2024 | 8-K Item 2.02 (results) | β |
| May 8, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Life Insurance
Metlife (MET)Prudential Financial (PRU)Corebridge Financial (CRBG)Reinsurance Group Of America (RGA)Jackson Financial (JXN)Voya Financial (VOYA)Lincoln National (LNC)Globe Life (GL)Manulife Financial (MFC)Aegon (AEG)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on FGN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.